Clinical Trial Update: Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether selenomethionine reduces mucositis in locally advanced head and neck cancer treated with cisplatin and radiation. The study was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Selenomethionine (selenomethionine)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Chemotherapeutic Agent Toxicity, Mucositis | Phase 2 | Status: TERMINATED | Results posted: 2014-08-22